Under the partnership, Sirona Dx oversees assay design, development and validation, ensuring quality image production.

PreludeDx® and Quanterix Corporation (Nasdaq: QTRX) today highlighted that AidaBREAST™, the first multi-omic assay to predict both locoregional recurrence risk and radiation therapy benefit in ...

Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a ...

As the “Method of the Year 2024”, spatial proteomics (SP) enables in situ characterization of protein localization, abundance ...

A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use – no coding required. C-COMPASS ...

SAMBAI, a team funded through the Cancer Grand Challenges initiative, reported that Akoya Biosciences’ PhenoCycler ®-Fusion system will be the foundational spatial proteomics technology used to ...

Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight ...

ST. LOUIS--(BUSINESS WIRE)--Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape TM system, the next generation in ChipCytometry TM instrumentation, advancing ...

The new platform delivers unmatched quantitation, robustness, and throughput to support clinical translation of spatial proteomics assays ORLANDO, Fla.--(BUSINESS WIRE)-- Bruker Corporation (BRKR) ...

Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by ...